Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-
like cells. Despite the relative frequency of IH and the potential severity of complications …

Despite their high incidence, most infantile haemangiomas (IH) do not require treatment as
they regress spontaneously and most do not leave significant sequelae. For the subset of …

Background The success of oral propranolol for treatment of infantile hemangiomas (IHs)
has led practitioners to use topical β‐blockers. In preterm infants, clinicians frequently turn to …

Propranolol has recently been reported to be a highly effective treatment for infantile
hemangioma (IH) and is emerging as a first‐line therapy. This study reports the observations …

Infantile hemangiomas (IH) are both the most common benign vascular tumors and the most
common soft tissue tumors in children, 1 characterized by a unique tripartite growth cycle of …

Abstract Aims and Objectives The purpose of this study was to compare the efficacy of orally
administered propranolol versus prednisolone versus both in the treatment of potentially …

Introduction Propranolol, a nonselective β-blocker, exerts an indirect effect on the
vasculature by leaving α-adrenergic receptors unopposed, resulting in peripheral …

Importance Ulceration is a common complication of infantile hemangioma (IH), which leads
to substantial morbidity. Ulceration in IH has not been systematically studied since the …

Infantile hemangiomas are the most common vascular tumors of infancy. A multidisciplinary
approach including dermatologists, otolaryngologists, plastic surgeons, hematologists …

Soft tissue damage stimulates sympathetic nerves to release large amounts of
catecholamine hormones which bind to β‐adrenergic receptors (β‐ARs) on the cell …